In ewes, anestrus results from a reduction in LH pulsatility due to an increased sensitivity of the hypothalamic estradiol negative feedback system. Considerable evidence has implicated the A15 group of dopaminergic neurons in the retrochiasmatic area in this seasonally dependent estradiol effect. Moreover, estradiol administered to the retrochiasmatic area in ovariectomized anestrous ewes inhibits LH secretion. However, A15 neurons do not appear to contain the classical estrogen receptors (ER␣). Therefore, we tested the hypothesis that ␤-estrogen receptors mediate the action of estradiol in the retrochiasmatic area by comparing the effects of estradiol and genistein, a selective ER␤ agonist. We also examined whether there are seasonal changes in response of the retrochiasmatic area to these agonists and if these effects are mediated by dopamine. To test these hypotheses, ovariectomized ewes were implanted with bilateral guide cannulae targeting the retrochiasmatic area. Crystalline agonists were administered via microimplants inserted down the cannulae. Blood samples taken before and 4 days after microimplant insertion were analyzed for LH concentrations, pulse frequency, and amplitude. Genistein treatment produced no significant change in LH levels in either season. Estradiol treatment decreased both mean LH concentrations and pulse frequency in anestrous but not breeding-season ewes. Administration of the dopamine antagonist sulpiride to ovariectomized ewes with estradiol microimplants in the retrochiasmatic area returned LH pulse frequency to levels indistinguishable from controls. From these data, we hypothesize that estradiol acts on local ER␣-containing neurons in this area to stimulate a dopaminergic pathway that inhibits LH secretion during anestrus.
INTRODUCTION
The ewe is a seasonal breeder, entering a period of infertility (anestrus) in late winter that lasts through the spring and summer months. This seasonal change is evident in circulating levels of tonically secreted LH. Similarly, ovariectomized (OVX) ewes treated with s.c. estradiol (E 2 ) implants exhibit a decline in LH concentration to undetectable levels, which lasts throughout the normal anestrous period [1, 2] . Because LH levels remain relatively constant in untreated OVX ewes, this decline in LH is attributed to a change in sensitivity to E 2 throughout the year. Thus, ewes become more sensitive to E 2 negative feedback during anestrus, and this sensitivity wanes as the fall and winter months approach.
Luteinizing hormone suppression by E 2 is believed to be mediated via the A15 DA neurons contained within the retrochiasmatic area (RCh). These neurons project to the median eminence, where they limit LH secretion, presumably through presynaptic inhibition of GnRH terminals [3, 4] . Destruction of these neurons by radiofrequency or chemical lesioning reduces the ability of E 2 to inhibit LH secretion in anestrus but not during the breeding season [5, 6] . Furthermore, these neurons have been shown to be activated in anestrous ewes by systemic E 2 exposure using both the early-immediate gene products Fos and Fos-related antigens [7] and amine metabolites as indices of activity [8, 9] . Administration of E 2 into the RCh in OVX ewes resulted in a significant decrease in LH pulse frequency [10, 11] during anestrus, raising the possibility that E 2 acts directly on A15 DA neurons. However, it is not clear whether this local response to E 2 in the RCh varies with season. Moreover, no classical estrogen receptors (ER␣) have been found in A15 DA neurons [12, 13] . The discovery of a second estrogen receptor subtype (ER␤) in the rat [14] , human [15] , and cow [16] raised the possibility that E 2 exerts its actions via this novel ER subtype within the A15 nucleus. The recent reports that ER␤ message could be measured and differentially localized within the RCh area of sheep [17, 18] supports this possibility.
The purpose of this experiment was to determine if there are seasonal changes in the response of the RCh to E 2 and to examine a role for ER␤ in the seasonal suppression of LH. We used E 2 and genistein, an ER␤-selective agonist [19] , to differentiate ER␣ versus ER␤ activity in anestrous and breeding season ewes. Additionally, we tested the hypothesis that the local effects of E 2 in the RCh on LH secretion are conveyed via DA neurons by administering a specific DA-D 2 receptor antagonist during E 2 treatment.
MATERIALS AND METHODS

Animals
Blackface ewes of mixed breeding were used for these studies. All ewes were housed outdoors until 3 days prior to surgery. Postsurgical animals remained indoors where the lighting condition for each experiment was adjusted twice per week to simulate the natural photoperiod. Each ewe received water ad libitum and a daily ration of silage and grain. All procedures involving animals were approved by the West Virginia University Animal Care and Use Committee.
Surgery
Bilateral ovariectomies were performed via midventral laparotomy under sodium pentobarbitol anesthesia, using sterile procedures. Following a 2-wk recovery period, chronic bilateral 18-gauge stainless steel guide can-847 SEASONAL ACTIONS OF E 2 IN THE RETROCHIASMATIC AREA nulae were stereotaxically placed into the hypothalamus under halothane anesthesia as previously described [20] . Guide cannulae were lowered until 2 mm dorsal to the target area of the RCh (A15 DA nuclei: approximately 2.5-3.0 mm lateral to midline, 0.5 mm caudal to the posterior border of the optic chiasm, level in the dorsoventral plane with the floor of the third ventricle). Ewes were allowed at least 2 wk to recover before beginning experiments. Anestrous experiments were carried out between April and August, while breeding-season experiments were performed between October and January.
Drugs
Crystalline 17␤-estradiol or genistein (Sigma-Aldrich, St. Louis, MO) were tamped (approximately 40 times) into the lumen of sterile 22-gauge stainless steel microimplants. Genistein was chosen based on in vitro data that it has a 20-fold higher affinity for ER␤ than ER␣ [19] and in vivo data demonstrating its effects on ER␤-dependent gene expression, but not ER␣ [21] . Within 30 min of tamping, microimplants were inserted down the guide cannulae so that they protruded 2 mm into the A15 cell group. The DA antagonist sulpiride (Sigma-Aldrich) was chosen for its specificity to D 2 receptors [22] and absence of reported clinical side effects [20, 23, 24] and was injected i.m. in 0.1 M tartaric acid at a dose of 1.2 mg/kg.
Serum Sampling
Blood samples (3 cm 3 ) were collected via jugular venipuncture at 12-min intervals. After clotting overnight at 4ЊC, serum was harvested and stored at Ϫ20ЊC until assayed for LH concentration.
Experimental Design Experiment 1. In this experiment, we tested the effects of genistein and E 2 delivered locally to the RCh area on LH suppression in anestrous ewes (n ϭ 15). Jugular blood samples were collected at intervals of 12 min for a 5-h period for assessment of pretreatment LH pulse patterns and mean LH concentration in OVX ewes with chronically implanted guide cannulae. Immediately following sampling, bilateral microimplant pairs containing either E 2 or genistein were placed in each animal. Frequent blood samples were again collected for 4 h on Day 4 after implantation; this time point was chosen based on previously published E 2 data [20] . Microimplants were then removed and animals were allowed 1 wk to recover before the same protocol was repeated in a crossover design. Upon completion of the final blood sampling, brain tissue was collected for histological analysis of microimplant locations. Experiment 2. Genistein and E 2 microimplants were administered to OVX breeding season ewes (n ϭ 8) to differentiate seasonal effects of these ligands within the RCh. Ewes were surgically prepared with guide cannulae and treated using the blood collection and treatment protocol as described above. Following completion, brain tissue was collected for histological analysis of microimplant locations. Experiment 3. This experiment was designed to test the role of DA neurons in mediating the locally administered E 2 effect on LH secretion during anestrus. The OVX ewes (n ϭ 11) were surgically prepared with guide cannulae as described above. Following recovery, blood samples were collected every 12 min for 4 h and then either E 2 or blank microimplant pairs were inserted into the RCh. Four days later, blood samples were collected for 4 h to determine the effect of E 2 or blank implants. Sulpiride was then injected and sampling continued for an additional 4 h to determine if the DA antagonist could disrupt E 2 actions. Microimplants were removed and all ewes were allowed a 1-wk recovery period before repeating the protocol in a crossover design. Histological analysis was used to exclude ewes with bilaterally misplaced microimplants as in experiments 1 and 2.
Tissue Analysis
Ewes were killed with an overdose of sodium pentobarbital (2 g) preceded by two heparin i.v. bolus injections (20 000 IU/injection, 10-min interval). Heads were removed and perfused with 6 L of 4% paraformaldehyde in 0.1 M phosphate buffer containing 2.5 IU heparin/ml and 0.1% NaNO 3 prior to collecting the brain. Hypothalami were dissected and postfixed for 24 h and then infiltrated with 20% sucrose in phosphate buffer. Hypothalami were sectioned into 50-m coronal slices using a freezing stage microtome for histological analysis of guide cannulae positions. Every fifth section was mounted onto gelatin-coated microscope slides and cover slipped after cresyl violet staining to visualize lesions created by the chronic guide cannulae. Sections rostral, through, and caudal to the lesion tracts were transcribed onto paper using a Bausch and Lomb overhead magnifying scope. Each microimplant placement was evaluated by comparing its location, measured 2 mm below the guide cannulae lesion and distance from midline (middle of third ventricle), to previously known locations of the A15 nucleus [11, 25] . Any ewes found to have microimplants completely outside these boundaries on both sides were considered misses.
Radioimmunoassay
Serum LH concentration was measured in 200-l aliquots by RIA using a modification of a previously described method [26] . Values are expressed in terms of the ovine standard, NIH S24. Radioiodinated ovine LH (LER1374A; Dr. L.E. Reichert, Jr., Albany Medical College, Albany, NY) was used as tracer, and primary antiserum was CSU-204 (Dr. Gordon Niswender, Colorado State University, Fort Collins, CO; dilution 1: 75 000). The sensitivity (95% confidence interval at 0 ng/ml) averaged 0.13 ng/tube over the 12 assays that contributed to the results. Intraassay coefficients of variation (CV) averaged 9.4% and 15%, respectively, for serum pools displacing radiolabeled LH to approximately 36% and 68% of the total bound, and interassay CVs were 12.5% and 25% for the same serum pools.
Statistical Analysis
The effects of treatments on LH pulse frequency in experiments 1 and 2, before and during treatments within seasons, were determined by the Wilcoxon-Mann-Whitney signed rank test. The effects on mean LH concentration were determined by ANOVA on repeated measures. Effects on LH pulse frequency among groups in experiment 3 were determined using Friedman repeated measures ANOVA on ranks. Mean LH concentrations were compared using two-way ANOVA for repeated measures. Amplitude data was analyzed using ANOVA. Results are presented Ϯ SEM, and P Ͻ 0.05 was defined as statistically significant.
RESULTS
Experiment 1: Does E 2 Act via ER-␤ to Suppress LH in Anestrus in the RCh?
Histological examination of implant lesions revealed accurate placements in 12 of 15 anestrous ewes (Fig. 1, Table  1 ). There was a significant decrease (P Ͻ 0.05) of LH pulse frequency (pulses/4 h) after 4 days of local RCh E 2 microimplants ( Fig. 2A) . Eleven of 12 ewes exhibited a drop in pulse frequency of at least one pulse per 4 h during E 2 microimplant treatment. In addition, the mean LH concentration was significantly reduced during treatment (Fig. 2B) . This fall was evident in 11 ewes, with no change in concentration for the nonresponder (12.6 versus 12.9 ng/ml). An example LH pulse pattern is shown in Figure 3A . The location of the microimplants for the nonresponding ewe was observed to be at the lateral edge of the A15 area, in close proximity to the optic tracts (Fig. 1) .
In contrast, genistein microimplants produced no significant changes in either LH pulse frequency or mean concentrations (Fig. 2 ). An example LH pulse pattern is shown in Figure 3B . Furthermore, there were no significant effects of either E 2 or genistein on pulse amplitudes ( Table 2 ). The three misplaced microimplant animals exhibited no change in LH pulse frequency (Table 3) , mean LH concentration, or amplitude (data not shown) following E 2 or genistein microimplant administration. Histological examination of implant lesions revealed accurate placements in five out of eight breeding-season ewes (Table 1) . Average LH pulse frequency (Fig. 4A ) during E 2 microimplantation was slightly lower than control due to a drop in one ewe, and mean LH concentration (Fig. 4B) FIG 
FIG. 2. LH pulse frequency (mean Ϯ SEM) (A) and mean LH concentration (B), pre-(open bars) and postmicroimplant placement (striped bars)
for accurately placed microimplant animals in experiment 1 (anestrus). *P Ͻ 0.05 versus pretreatment value. declined slightly during E 2 microimplant treatment, but both were not significant changes (P Ͼ 0.05). Furthermore, there was a nonsignificant decrease in LH pulse amplitudes (P ϭ 0.09, Table 2 ) which contributed to the nonsignificant decline in mean LH concentration in three of the five ewes. There was no apparent correlation between microimplant placement within the A15 area and the differences seen in LH measurements. Genistein microimplants did not significantly alter pulse frequency, mean LH concentrations (Fig.  4) , or pulse amplitudes (Table 2) . Luteinizing hormone pulse frequency in the three animals with misplaced microimplants was unaltered by either E 2 or genistein (Table  3) , as was mean LH concentration and pulse amplitude (data not shown). Histological examination of microimplant lesions revealed accurate placements in 7 of 11 ewes ( Table 1) . As expected, E 2 microimplants significantly reduced LH pulse frequency during treatment, an effect clearly evident in this group (Fig. 5A , P Ͻ 0.05 versus control). As with experiment 1, a single nonresponder had microimplants that were at the lateral borders of the A15 area. Sulpiride was effective in blocking E 2 actions and returned pulse frequency to pretreatment levels (P Ͻ 0.05 versus E 2 ). Mean LH concentrations showed similar trends (Fig. 5B) , with E 2 tending to reduce LH and sulpiride treatment tending to block this effect; however, these results did not attain significance (P ϭ 0.20). Luteinizing hormone pulse amplitude was not significantly affected by E 2 or sulpiride (22.2 Ϯ 7.8 ng/ml before, 14.7 Ϯ 4.4 during E 2 treatment, and 15.8 Ϯ 6.1 after sulpiride injection, P Ͼ 0.05). Blank implants had no effect on LH pulse frequency (Fig. 4A) , mean LH concentration (Fig. 5B) , or LH pulse amplitude (24.6 Ϯ 9.2 ng/ml versus 29.0 Ϯ 8.7 and 31.8 Ϯ 9.6 after sulpiride injection, P Ͼ 0.05). In the four ewes with misplaced microimplants, no significant effects of treatment on LH pulse frequency, mean concentration, or amplitude were observed (Table 4) .
DISCUSSION
The results of this study indicate that local delivery of crystalline E 2 into the RCh suppresses LH in a seasonally dependent fashion. Specifically, E 2 administration resulted in the reduction of LH frequency as well as mean LH concentrations in OVX anestrous ewes. However, E 2 was unable to alter serum LH frequency or concentration during the breeding season. Moreover, E 2 appears to exert these actions via an inhibitory DA system because sulpiride injections were successful in reversing the effects of E 2 microimplants. These results confirm and extend the observation of Gallegos-Sanchez et al. [11] that E 2 microimplants in the RCh inhibit LH secretion in anestrous ewes.
Because A15 DA cells in the RCh do not appear to contain ER␣ [12] , one simple explanation for these results is that E 2 is acting via ER␤ in A15 cells. However, the lack of LH response to genistein microimplants does not support this hypothesis. It is possible that the estradiol was reaching a larger number of neurons than genistein, but based on their structures and relative solubility [27] , it seems more likely that the volume of diffusion for genistein is greater than that of estradiol. Another explanation for the lack of effect of genistein is that it does not act at ER␤ sites in the ovine RCh. However, competitive binding was demonstrated between genistein and 17␤-estradiol in ovine pituitary and hypothalamic cytosol, indicating genistein may interfere with E 2 negative feedback mechanisms [28] . Moreover, it has been shown to be an effective protein tyrosine kinase inhibitor [29, 30] . Also, in the rat hemipituitary, genistein was effective in reducing GnRH-induced LH secretion [31] , while significantly affecting ER␤-dependent gene expression in the ventromedial nucleus [21] . Given these data, we argue that ER␤ has no role in the seasonal suppression of GnRH by E 2 negative feedback in the ewe. In further support of this conclusion, Lubbers et al. [32] failed to localize ER␤ in DA neurons of the A15. Furthermore, ER␤ knockout mice continue to exhibit normal reproductive behaviors and functions [33, 34] , while ER␣ knockout mice display abnormally high plasma gonadal steroid levels. Thus, ER␣ appears to be the predominant ER involved in steroid negative feedback in this species [35] . The role of ER␤, if any, has yet to be elucidated in the neuroendocrine regulation of reproduction. The effectiveness of E 2 microimplants targeting the A15 in suppressing LH via a DA pathway remains somewhat paradoxical because these DA neurons do not contain ER␣ [12] . One possible explanation is that E 2 is diffusing from the site of implantation to other DA perikarya, such as A14 neurons. Some A14 neurons rostral to the A15 contain ER␣ [12] . But histological analysis revealed that E 2 appears to act in an anatomically restricted zone of the RCh, encompassing the A15 nuclei. Specifically, microimplants that were misplaced more than 1 mm rostral or caudal to the A15, including those in the region of A14 perikarya, had no effect on LH secretion. These data are consistent with estimates that radiolabeled steroid diffusion in ovine neural tissue is limited to approximately 1 mm [36, 37] . Several other studies have also shown E 2 microimplants to act in a site-specific manner [11, 24, [36] [37] [38] . Another possible explanation for these findings is that E 2 may act via nongenomic pathways involving membrane-associated ER [39, 40] . However, effects of a nongenomic mode of action are usually seen within minutes [41] . Greater than 16 h are required before the negative feedback effects of E 2 are observed, a time course more compatible with actions mediated by nuclear receptors [7, 10] . Therefore, we postulate that E 2 -receptive interneurons exist in the RCh that directly or indirectly stimulate DA release. Preliminary analysis of tissue following injection of a retrograde tract tracer into the A15 indicates the presence of ER␣-containing afferents in close proximity to the A15 area [42] .
Recently, a group of ER␣-immunopositive neurons found in the ventromedial preoptic area (vmPOA) have also been implicated in E 2 negative feedback [43] . These neurons are responsive to E 2 [43] and also suppress LH pulse frequency during anestrus via a DA inhibitory pathway [20] . These data, together with the findings presented here and results from several preliminary neural tract-tracing studies [42, 44, 45] , support the existence of a previously undescribed neural network involved with the seasonal in- hibition of GnRH. Specifically, tract tracers, when injected into the vmPOA, are transported to nerve terminals in the A15 and the area just mediodorsal and caudal to the A15 nucleus [45] . These tract-tracing studies as well as the present E 2 -microimplant results support the existence of a neural network that extends from the vmPOA to the A15/RCh area, including the A15-associated cells, and then extends via A15 efferents on to GnRH terminals within the median eminence (ME). Furthermore, we have preliminary evidence that demonstrates an increase in synaptic connections associated with the A15 cells during anestrus [46] . This may account for the ability of the postulated vmPOA-RCh-ME system to suppress GnRH during anestrus, not the breeding season.
The findings of this study support prior research concerning seasonal changes in E 2 negative feedback acting through an inhibitory DA pathway. The DA activity of A15 neurons is increased during anestrus following systemic E 2 exposure [8, 9] in OVX ewes, and ablation of these neurons disrupts E 2 inhibition of LH at this time [5, 9] . Furthermore, microimplants containing the DA antagonist pimozide and microdialysis of sulpiride or ␣-methyl-para-tyrosine (but not D 1 -receptor analogs) into the ME disinhibit LH secretion in anestrous ewes [47, 48] , suggesting a D 2 receptor-dependent inhibition of GnRH secretion by DA. Our results, taken together with the sulpiride data from Anderson et al. [20] , extends these findings and provides a developing, functional picture as to how the RCh and vmPOA E-responsive neurons interact to alter GnRH secretion. While local E 2 in each area significantly reduced LH, microimplants in neither site were as effective as systemic E 2 treatment [11, 20] . One explanation for this quantitative difference is that the E 2 in the microimplants is not reaching all the E 2 -receptive neurons in the RCh or vmPOA. If this is the case, the two populations of E 2 -receptive neurons would be redundant such that one or the other population of cells is required for seasonal anestrus. Alternatively, these two areas might act in concert to establish the efficacy of E 2 negative feedback seen in peripherally treated OVXϩE ewes.
In summary, the results of this experiment lead to the hypothesis that a group of E 2 -responsive, A15-associated cells in the RCh contribute to seasonal changes in E 2 negative feedback in the ewe. Microimplants delivering E 2 to these neurons result in the stimulation of DA neurons, which in turn inhibit GnRH secretion. Further studies are needed to elucidate the location and identity of these A15-associated cells and to determine their role in E 2 negative feedback.
